BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21681380)

  • 1. Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis.
    Mayo SC; de Jong MC; Bloomston M; Pulitano C; Clary BM; Reddy SK; Clark Gamblin T; Celinski SA; Kooby DA; Staley CA; Stokes JB; Chu CK; Arrese D; Ferrero A; Schulick RD; Choti MA; Geschwind JF; Strub J; Bauer TW; Adams RB; Aldrighetti L; Mentha G; Capussotti L; Pawlik TM
    Ann Surg Oncol; 2011 Dec; 18(13):3657-65. PubMed ID: 21681380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis.
    Mayo SC; de Jong MC; Pulitano C; Clary BM; Reddy SK; Gamblin TC; Celinksi SA; Kooby DA; Staley CA; Stokes JB; Chu CK; Ferrero A; Schulick RD; Choti MA; Mentha G; Strub J; Bauer TW; Adams RB; Aldrighetti L; Capussotti L; Pawlik TM
    Ann Surg Oncol; 2010 Dec; 17(12):3129-36. PubMed ID: 20585879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Net health benefit of hepatic resection versus intraarterial therapies for neuroendocrine liver metastases: A Markov decision model.
    Spolverato G; Vitale A; Ejaz A; Kim Y; Cosgrove D; Schlacter T; Geschwind JF; Pawlik TM
    Surgery; 2015 Aug; 158(2):339-48. PubMed ID: 25999251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery.
    Saxena A; Chua TC; Zhao J; Morris DL
    J Surg Oncol; 2012 Mar; 105(4):342-50. PubMed ID: 22006355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.
    Martin RC; Edwards MJ; McMasters KM
    Am J Surg; 2004 Dec; 188(6):714-21. PubMed ID: 15619489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis.
    Pawlik TM; Gleisner AL; Bauer TW; Adams RB; Reddy SK; Clary BM; Martin RC; Scoggins CR; Tanabe KK; Michaelson JS; Kooby DA; Staley CA; Schulick RD; Vauthey JN; Abdalla EK; Curley SA; Choti MA; Elias D
    Ann Surg Oncol; 2007 Oct; 14(10):2807-16. PubMed ID: 17551795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms.
    Cho CS; Labow DM; Tang L; Klimstra DS; Loeffler AG; Leverson GE; Fong Y; Jarnagin WR; D'Angelica MI; Weber SM; Blumgart LH; Dematteo RP
    Cancer; 2008 Jul; 113(1):126-34. PubMed ID: 18457323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous resection of primary and liver metastases for neuroendocrine tumors.
    Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y
    Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of disease occurrence and hepatic resection on long-term outcome of patients with neuroendocrine liver metastasis.
    Zhang XF; Beal EW; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
    J Surg Oncol; 2018 Feb; 117(2):171-181. PubMed ID: 28940257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment efficacy of surgical management for liver metastasis from colorectal cancer--a report of 198 cases].
    Zhang ZG; Song C; Wang H
    Ai Zheng; 2006 May; 25(5):596-8. PubMed ID: 16687081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical strategy for liver metastases of neuroendocrine tumors.
    Tsuchikawa T; Hirano S; Tanaka E; Kato K; Matsumoto J; Nakayama T; Tabata Y; Shichinohe T
    Hepatogastroenterology; 2012 May; 59(115):921-3. PubMed ID: 22024223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.
    Birnbaum DJ; Turrini O; Vigano L; Russolillo N; Autret A; Moutardier V; Capussotti L; Le Treut YP; Delpero JR; Hardwigsen J
    Ann Surg Oncol; 2015 Mar; 22(3):1000-7. PubMed ID: 25190116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the surgical effort in patients with advanced neuroendocrine neoplasm hepatic metastases: a critical analysis of 40 patients treated by hepatic resection and cryoablation.
    Saxena A; Chua TC; Chu F; Al-Zahrani A; Morris DL
    Am J Clin Oncol; 2012 Oct; 35(5):439-45. PubMed ID: 21654315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
    Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
    Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer.
    Aoki T; Sugawara Y; Imamura H; Seyama Y; Minagawa M; Hasegawa K; Kokudo N; Makuuchi M
    J Am Coll Surg; 2004 Mar; 198(3):366-72. PubMed ID: 14992737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
    Reddy SK; Tsung A; Marsh JW; Geller DA
    J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic neuroendocrine hepatic tumors: resection improves survival.
    Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
    Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study.
    Elias D; Lasser P; Ducreux M; Duvillard P; Ouellet JF; Dromain C; Schlumberger M; Pocard M; Boige V; Miquel C; Baudin E
    Surgery; 2003 Apr; 133(4):375-82. PubMed ID: 12717354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.